Table 1.

Demographic and Clinical Characteristics of the Participants (n=105)

Characteristic	Mean or N	SD or %
Age, years	11.2	2.7
Tanner Stage: I, II, III, IV, V	48/16/13/21/7	46/15/12/20/7
Anthropometry*
Baseline Weight z-score (n=80)	0.1	1.1
Final Weight, kg (n=105)	44.8	17.0
Final Weight z-score (n=105)	0.6	1.1
Baseline BMI z-score (n=79)	0.1	1.1
Final BMI, kg/m2 (n=105)	20.0	3.8
Final BMI z-score (n=105)	0.7	1.0
Final Percent Body Fat (n=97)	20.4	8.9
Final Waist Circumference, cm (n=98)	70.2	12.7
Final Blood Pressure (n=105)
Systolic Blood Pressure, mmHg	107.4	11.5
Systolic Blood Pressure z-score	0.2	1.0
Diastolic Blood Pressure, mmHg	61.7	8.3
Diastolic Blood Pressure z-score	−0.0	0.7
Mean Arterial Pressure, mmHg	77.0	8.4
Pulse Pressure, mmHg	45.7	9.5
Heart Rate, bpm	84.5	14.2
Final Glucose Homeostasis†
Glucose, mg/dl (n=93)	90.0	8.3
Total Insulin, μUI/ml (n=92)	6.7	4.8
C-Peptide, ng/ml (n=46)	1.7	0.6
HOMA-IR (n=92)	1.5	1.1
Final Lipids† (n=92)
HDL Cholesterol, mg/dl	57.7	13.9
Total Cholesterol, mg/dl	158.4	24.6
LDL Cholesterol, mg/dl	88.5	21.1
Non-HDL Cholesterol, mg/dl	100.9	25.1
Triglycerides, mg/dl	59.9	35.8
Triglycerides/HDL Cholesterol Ratio	1.2	0.9
Final Metabolic Syndrome Score‡ (n=92)	−0.0	3.2
Final Regulatory Hormones†
Leptin, ng/ml (n=92)	5.6	5.2
Adiponectin, μg/ml (n=46)	15.0	7.0
Active Ghrelin, pg/ml (n=44)	237.0	150.5
Final Inflammatory Marker†
High Sensitivity C-reactive Protein, mg/l (N=47)	0.6	1.2

Legend for Table 1:

^*The measurements were made at study enrollment except for the baseline weight and BMI ones.

^†Only fasting samples are included, except for hsCRP. One participant with hsCRP > 5 mg/l and one with a triglyceride concentration of 601 mg/dl were excluded.

^‡The metabolic syndrome score was generated following Eisenmann.